✦ LIBER ✦

Randomized phase II trial of non-platinum induction or consolidation chemotherapy plus concomitant chemoradiation in stage III NSCLC patients: Mature results of the Spanish Lung Cancer Group 0008 study

✍ Scribed by Garrido, Pilar; Rosell, Rafael; Arellano, Antonio; Andreu, Francisco; Dómine, Manuel; Perez-Casas, Ana; Cardenal, Felipe; Arnaiz, María del Mar; Morán, Teresa; Morera, Rosa; Isla, Dolores; Valencia, Javier; Cobo, Manuel; Delgado, Raquel; García-Gómez, Ramón; Calvo, Felipe; Zamora, Javier; Ramos, Alfredo; Massutí, Bartomeu

Book ID: 122451045
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 853 KB
Volume: 81
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2013.03.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6500 ORAL Randomized phase II trial usin

6500 ORAL Randomized phase II trial using concomitant chemoradiation plus induction (I) or consolidation (C) chemotherapy (CT) for unresectable stage III non-small cell lung cancer (NSCLC) patients (pts). Mature results of the SLCG 0008 study

✍ Garrido, P.; Massuti, B.; Jimenez, A.; Samper, P.; Mesia, C.; Rodriguez, N.; Lia 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Predictors of Long-Term Survival in Pati

Predictors of Long-Term Survival in Patients with Lung Cancer Included in the Randomized Spanish Lung Cancer Group 0008 Phase II Trial Using Concomitant Chemoradiation with Docetaxel and Carboplatin plus Induction or Consolidation Chemotherapy

✍ Pilar Garrido; Rafael Rosell; Bartomeu Massutí; Felipe Cardenal; Vicente Alberol 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 130 KB

PD-042 Induction (I) or consolidation (C

PD-042 Induction (I) or consolidation (C) chemotherapy withdocetaxel (D) and gemcitabine (G) plus concomitant chemoradiotherapy (CT/TRT) with docetaxel and carboplatin (Cb) for unresectable stage III non-small cell lung cancer (NSCLC) patients (p). Initial report of the randomized phase II trial SLCG 0008

✍ Garrido, P.; Resell, R.; Arellano, A.; Ramos, A.; Massuti, T.; Andreu, J.; Carde 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

319 oral Mature results of a multicenter

319 oral Mature results of a multicenter German/French Phase-II trial of induction chemotherapy (CT) followed by hyperfractionated accelerated thoracic radiotherapy (HATRT) concurrent with CT followed or not by surgery (S) in inoperable non-small-cell lung cancer (NSCLC) stage III patients

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 125 KB

P-554 Randomized Phase II study of first

P-554 Randomized Phase II study of first-line docetaxel (D)/ gemcitabine (G) doublet chemotherapy versus fixed duration (3 cycles) sequential single agent chemotherapy (D then G) in Stage IIIB/IV non-small cell lung cancer (NSCLC)—Final Results. A study by the NSW and Australian Lung Cancer Trials Group

✍ Pavlakis, N.; McCowatt, S.; Lewis, C.; Marx, G.; Abell, F.; Della-Fiorentina, S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

O-040 Randomized phase III trial for sta

O-040 Randomized phase III trial for stage III unresectable nonsmall cell lung (NSCLC) cancer: Induction Chemotherapy (ICT) [vinorelbine (Vr)-cisplatine (P)] followed by conventional radiation (RT) without (arm A) or with daily carboplatin (Cb) (arm B). Final results. Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT

✍ Douillard, J.; Gervais, R.; Quoix, E.; Le Chevalier, T.; Le Groumellec, A.; Lema 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB